“…Though this brings in patient-to-patient variability ( Table 1 ), these approaches maintain some of the in vivo characteristics such as cytoskeletal organization ( Menon et al, 2018 ; Richardson et al, 2018b , 2020b ), endocrine and paracrine signaling ( Myatt and Sun, 2010 ; Behnia et al, 2015 ), inflammatory responses ( Menon et al, 2009 ; Noda-Nicolau et al, 2016 ), as well as immune regulatory factors ( Fortunato et al, 1998 , 2001 ). Protocols documenting amnion (i.e., AEC and AMC) cell isolation techniques are well established ( Kendal-Wright, 2007 ; Menon et al, 2013 ; Sato et al, 2016 ; Jin et al, 2018 ). However, although it is not impossible to isolate and culture primary chorion mesenchymal and trophoblast cells (CMC and CT) [99, 108], due to many in vitro challenges (isolation, culture conditions, passage-related issues, and transition properties), researchers have turned to use immortalized placenta-based trophoblast cells (i.e., BEWO and JEG-3) derived from carcinomas to replicate this layer [109].…”